Document is current

Any future updates will be listed below

Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s10194-020-01138-x

Published Online: 2020-06-05

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark